The Expression of BRAK/CXCL14 and RhoA in Human Renal Cell Carcinoma
碩士 === 高雄醫學大學 === 生物化學研究所碩士班 === 93 === Renal-cell carcinoma (RCC) is a very difficult tumor to treat, and response rates to biological therapies are less than 20%. The identification of various molecular and cellular markers has led to the development of novel therapies. We first used the microarra...
Main Authors: | Chuang-Wei Wang, 王壯維 |
---|---|
Other Authors: | Tzyh-Chyuan Hour |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/52403005178934991975 |
Similar Items
-
Chemokine CXCL14 (BRAK) Expression and potential role in human renal cell carcinoma
by: Yuan-Hung Pong, et al.
Published: (2015-06-01) -
Molecular role of chemokine CXCL14 (BRAK) in human renal cell carcinoma
by: Fei-Tsuei Liu, et al.
Published: (2009) -
The molecular mechanism of chemokine CXCL14(BRAK) induced the migration of human renal cell carcinoma, A-498 cells
by: Nian-Zu Chen, et al.
Published: (2013) -
Fasudil Suppresses Fibrosarcoma Growth by Stimulating Secretion of the Chemokine CXCL14/BRAK
by: Chihiro Miyamoto, et al.
Published: (2012-01-01) -
Silencing of <it>RhoA </it>and <it>RhoC </it>expression by RNA interference suppresses human colorectal carcinoma growth in vivo
by: Wang Haibo, et al.
Published: (2010-09-01)